BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Policy

  TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR

  The Company expects to learn of the acceptance of the NDA resubmission within 30 calendar days.

  November 29, 2017

   · 

  4 min read
• Pharm Country

  AmerisourceBergen Prices $750M 3.45% Senior Notes Due 2027 and $500M 4.30% Senior Notes Due 2047

  The offering is expected to close on December 4, 2017, subject to customary closing conditions.

  November 29, 2017

   · 

  8 min read
• Dynatronics Holds Annual Meeting of Shareholders

  Results of the voting and other information relating to the company’s Annual Meeting of Shareholders will be reported by the company in a Current Report on Form 8-K to be filed with the SEC.

  November 29, 2017

   · 

  3 min read
• Business

  Revive Therapeutics Announces Results for the Three Months Ended September 30, 2017

  The unaudited condensed interim consolidated financial statements and related interim management’s discussion and analysis for the three months ended September 30, 2017 may be viewed on SEDAR at www.sedar.com.

  November 29, 2017

   · 

  6 min read
• 

  Deals

  Struggling The Medicines Company Deals Its Infectious Disease Biz to Melinta for $270M

  The Medicines Company is selling its infectious disease business unit to Melinta Therapeutics.

  November 29, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  2-Year Old Codiak Lands Another $76.5M, Bringing Its Total Raise to $168.5M

  The company indicates it plans to use the proceeds from the latest financing to move its lead product candidates into clinical trials and to continue developing its exosome therapeutic platform.

  November 29, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Alkermes Allegedly Fired 3 Female Employees Who Raised Concerns of Bias

  After being criticized earlier this month by U.S. Sen. Kamala Harris, three separate sexual harassment lawsuits have been reported.

  November 29, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Troubled Otonomy Cuts Jobs, Ceases Programs Related to Otiprio

  Otonomy said dropping the program and terminating the employees will provide a cash savings of more than $20M in 2018.

  November 29, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  BioForest

  Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now

  Omeros is getting a lot of love from investors and analysts these days.

  November 29, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Why This Small SoCal Biotech’s Pipeline Makes it Flushed for Growth

  Nobody is interested in slow-growth or no-growth stocks, long term or short term, but everyone’s interested in fast-growing stocks.

  November 29, 2017

   · 

  3 min read

   · 

  Mark Terry